FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-003-0601-4 ◽

2003 ◽

Vol 52 (4) ◽

pp. 339-345 ◽

Cited By ~ 3

Author(s):

Juan José Reina ◽

Jorge Aparicio ◽

Javier Salvador ◽

José María Puerto Pica ◽

Antonio Rueda ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6605075 ◽

2009 ◽

Vol 100 (11) ◽

pp. 1720-1724 ◽

Cited By ~ 22

Author(s):

E Vasile ◽

G Masi ◽

L Fornaro ◽

S Cupini ◽

F Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer

Investigational New Drugs ◽

10.1007/s10637-011-9779-1 ◽

2011 ◽

Vol 30 (5) ◽

pp. 2026-2031 ◽

Cited By ~ 7

Author(s):

Natsuko T. Okita ◽

Taito Esaki ◽

Eishi Baba ◽

Daisuke Sakai ◽

Shinya Tokunaga ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Stop And Go ◽

Modified Folfox6 ◽

Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial)

Oncology Letters ◽

10.3892/ol.2016.5505 ◽

2016 ◽

Vol 13 (2) ◽

pp. 747-753 ◽

Cited By ~ 3

Author(s):

Masanori Kotake ◽

Toru Aoyama ◽

Yoshinori Munemoto ◽

Kenji Doden ◽

Masato Kataoka ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

420P A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.941 ◽

2021 ◽

Vol 32 ◽

pp. S545

Author(s):

K. Ding ◽

Y. Liu ◽

J. Du ◽

Y. Zhu ◽

D. Xu ◽

...

Keyword(s):

Colorectal Cancer ◽

Unresectable Metastatic Colorectal Cancer

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Multicenter Phase ◽

First Line Treatment ◽

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First‐Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG‐1201 Study)

The Oncologist ◽

10.1634/theoncologist.2017-0640 ◽

2018 ◽

Vol 23 (8) ◽

pp. 919-927 ◽

Cited By ~ 1

Author(s):

Goro Nakayama ◽

Ayako Mitsuma ◽

Yuki Sunagawa ◽

Kiyoshi Ishigure ◽

Hiroyuki Yokoyama ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Japanese Patients ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study

BMC Cancer ◽

10.1186/1471-2407-10-567 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 33

Author(s):

Gemma Bruera ◽

Alessandra Santomaggio ◽

Katia Cannita ◽

Paola Lanfiuti Baldi ◽

Marianna Tudini ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G

Annals of Oncology ◽

10.1093/annonc/mdy281.151 ◽

2018 ◽

Vol 29 ◽

pp. viii201

Author(s):

Y. Kito ◽

T. Yamada ◽

T. Matsumoto ◽

H. Yasui ◽

K. Murata ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6603493 ◽

2007 ◽

Vol 96 (3) ◽

pp. 439-444 ◽

Cited By ~ 21

Author(s):

E Bajetta ◽

◽

M Di Bartolomeo ◽

R Buzzoni ◽

L Mariani ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Colorectal Cancer Patients ◽

A phase II study of biweekly irinotecan (CPT-11) and 5-fluorouracil (5-FU) as first line treatment in advanced or metastatic colorectal cancer (CRC)

European Journal of Cancer ◽

10.1016/s0959-8049(01)81582-3 ◽

2001 ◽

Vol 37 ◽

pp. S295-S296 ◽

Cited By ~ 1

Author(s):

J. Salvador ◽

R. Bernabe ◽

M. Bolaños ◽

P. Borrega ◽

M. Valladares ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽